Replimune Group, Inc. (REPL) Cash Flow Statement

NASDAQ: REPLOperating cash, capex, free cash flow and buybacks.

Where REPL’s cash came from and went, FY2026

March 31, 2026 · U.S. dollars
Cash from operations
−$280.3M
Capital expenditures
$4.2M
Free cash flow
−$284.6M
Returned to shareholders
—
Change in cash
$97.9M
cash at year-end $210.7M
Investments (net): $315.1MInvestments (net)$315.1MBorrowing: $34.3MBorrowing$34.3MShares issued: $31.1MShares issued$31.1MCurrency & other: $2.0MCurrency & other$2.0MCash used in operations: $280.3MCash used in operations$280.3M · 73%Added to cash: $97.9MAdded to cash$97.9M · 26%Capital expenditures: $4.2MCapital expenditures$4.2M · 1%$382.5M
Cash from operations
−$280.3M
Capital expenditures
−$4.2M
Investments (net)
+$315.1M
Net borrowing (repayment)
+$34.3M
Shares issued
+$31.1M
Currency & other
+$2.0M
Change in cash
$97.9M

Drawn to scale: where the cash came from and how it was used. Hover for values.

REPL operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

REPL cash flow trends, FY2017–FY2026

Replimune Group, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$7.1MFY2017−$280.3MFY2026—
Capital expenditures$238,000FY2017$4.2MFY2026+37.7%/yr
Free cash flow−$7.3MFY2017−$284.6MFY2026—
Stock-based compensation$208,000FY2017$32.3MFY2026+75.2%/yr
Dividends paid$28.1MFY2020$91.7MFY2021+225.6%/yr
Share buybacks (net)$0FY2017$0FY2023—

Change is the average annual growth (CAGR) or the difference between the first and latest year.

REPL cash flow by activity

OperatingInvestingFinancingChange in cash

REPL net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

REPL cash flow statement

Replimune Group, Inc. annual cash flow statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating activities
Net income−$313.9M−$247.3M−$215.8M−$174.3M−$118.0M−$80.9M−$52.6M−$30.8M−$19.7M−$7.7M
Depreciation & amortization$3.3M$3.5M$2.7M$2.4M$2.1M$1.7M$533,000$148,000$109,000$122,000
Stock-based compensation$32.3M$35.0M$34.1M$28.1M$24.3M$11.8M$7.7M$2.7M$812,000$208,000
Change in working capital−$3.8M$24.1M$5.5M$15.1M$7.2M$3.5M−$15.4M−$1.3M$1.9M$147,000
Other non-cash items$1.8M−$7.6M−$11.9M$532,000$2.2M$2.5M−$789,000$3.8M$875,000$150,000
Cash from operating activities−$280.3M−$192.2M−$185.5M−$128.1M−$82.2M−$61.4M−$60.6M−$25.4M−$16.0M−$7.1M
Investing activities
Capital expenditures−$4.2M−$6.7M−$5.7M−$2.3M−$2.3M−$2.4M−$6.5M−$2.6M−$136,000−$238,000
Investments (net)$315.1M−$23.8M$97.2M−$142.5M$530,000−$186.4M$1.3M−$63.3M−$44.0M−$238,000
Acquisitions & other investing$0$6.7M$5.7M$2.3M$0$0$0$0$136,000$238,000
Cash from investing activities$310.8M−$23.8M$97.2M−$142.5M−$1.8M−$188.8M−$5.2M−$65.9M−$44.0M−$238,000
Financing activities
Dividends paid—————−$91.7M−$28.1M———
Share repurchases & issuance (net)———$92.8M—$91.7M$28.1M$101.4M$54.8M$15.0M
Net borrowing (repayment)$34.3M−$599,000$14.5M$27.8M−$264,000−$10.8M$10.0M$9.9M$9.9M$9.9M
Shares issued$31.1M$155.7M$0$187.3M$31.0M$286.1M$61.9M$103.3M$0$0
Other financing$883,000$97.3M$1.8M$3.4M−$24.2M$97.2M$28.3M−$113.3M−$9.9M−$9.9M
Cash from financing activities$66.3M$252.4M$16.3M$311.3M$6.6M$372.5M$100.2M$101.4M$54.8M$15.0M
Summary
Net change in cash$97.9M$36.7M−$72.1M$40.6M−$76.6M$123.0M$34.2M$9.2M−$3.0M$6.3M
Cash at end of period$210.7M$112.8M$76.2M$148.2M$107.6M$184.2M$61.1M$26.9M$17.7M$20.7M
Free cash flow−$284.6M−$198.9M−$191.1M−$130.3M−$84.5M−$63.8M−$67.1M−$28.0M−$16.1M−$7.3M

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

REPL cash generation

In fiscal 2026 (ended March 31, 2026), Replimune generated -$280.3 million of cash from operations and spent $4.2 million on capital expenditures, leaving free cash flow of -$284.6 million. Cash and equivalents rose by $97.9 million over the year.

Related: REPL income statement, REPL balance sheet. See the REPL stock overview for the latest quote and news.

REPL cash flow FAQ

What is Replimune's free cash flow?

Replimune's free cash flow was -$284.6 million in fiscal 2026: -$280.3 million of operating cash flow minus $4.2 million of capital expenditures It was -$198.9 million a year earlier..

How much cash does Replimune generate from operations?

Replimune generated -$280.3 million of cash from operating activities in fiscal 2026.

How much does Replimune spend on capital expenditures?

Replimune spent $4.2 million on capital expenditures in fiscal 2026, compared with $6.7 million the year before.

Biotechnology: cash flow